Drug Approval | August 28, 2025
Gilead’s Yeytuo approved in EU for HIV prevention
This authorization follows FDA approval in June and WHO’s July recommendation adding twice-yearly lenacapavir as a PrEP option
This authorization follows FDA approval in June and WHO’s July recommendation adding twice-yearly lenacapavir as a PrEP option
Vasograin Plus represents a major advancement in the treatment of migraine
The agency concluded that for people of all ages, IXCHI should be administered when there is a significant risk of chikungunya infection
Vevzuo is authorized for the prevention of skeletal related events in adults with advanced malignancies involving bone
A triple-action Formula for comprehensive respiratory relief
BRAVE study will explore the potential of omaveloxolone to address the critical unmet need of the pediatric FA population
The approval is for the generic version of Victoza, indicated for the treatment of insufficiently controlled Type 2 Diabetes Mellitus
Breztri is an inhaled triple-combination therapy approved for the treatment of chronic obstructive pulmonary disease
PCC has secured the commercialization rights for the EU, UK, and Norway and will be responsible for distributing Neoatricon in these regions
Around 100 million people live with COPD in China, accounting for almost 25% of all COPD cases globally
Subscribe To Our Newsletter & Stay Updated
